These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 21231902)
1. Optimization of a polymer composite employing molecular mechanic simulations and artificial neural networks for a novel intravaginal bioadhesive drug delivery device. Ndesendo VM; Pillay V; Choonara YE; du Toit LC; Kumar P; Buchmann E; Meyer LC; Khan RA Pharm Dev Technol; 2012; 17(4):407-20. PubMed ID: 21231902 [TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of the release of zidovudine and polystyrene sulfonate from a dual intravaginal bioadhesive polymeric device in the pig model. Ndesendo VM; Pillay V; Choonara YE; Du Toit LC; Meyer LC; Buchmann E; Kumar P; Khan RA J Pharm Sci; 2011 Apr; 100(4):1416-35. PubMed ID: 20960571 [TBL] [Abstract][Full Text] [Related]
3. Investigation of the physicochemical and physicomechanical properties of a novel intravaginal bioadhesive polymeric device in the pig model. Ndesendo VM; Pillay V; Choonara YE; du Toit LC; Buchmann E; Meyer LC; Khan RA; Rosin U AAPS PharmSciTech; 2010 Jun; 11(2):793-808. PubMed ID: 20446071 [TBL] [Abstract][Full Text] [Related]
4. Advanced preformulation investigations for the development of a lead intravaginal bioadhesive polymeric device. Ndesendo VM; Pillay V; Choonara YE; du Toit LC; Buchmann E; Kumar P; Khan RA; Meyer LC Drug Dev Ind Pharm; 2012 Mar; 38(3):271-93. PubMed ID: 21851308 [TBL] [Abstract][Full Text] [Related]
5. In vitro and ex vivo bioadhesivity analysis of polymeric intravaginal caplets using physicomechanics and computational structural modeling. Ndesendo VM; Pillay V; Choonara YE; Khan RA; Meyer L; Buchmann E; Rosin U Int J Pharm; 2009 Mar; 370(1-2):151-9. PubMed ID: 19114098 [TBL] [Abstract][Full Text] [Related]
6. In vivo evaluation of a mucoadhesive polymeric caplet for intravaginal anti-HIV-1 delivery and development of a molecular mechanistic model for thermochemical characterization. Ndesendo VM; Choonara YE; Meyer LC; Kumar P; Tomar LK; Tyagi C; du Toit LC; Pillay V Drug Dev Ind Pharm; 2015; 41(8):1274-87. PubMed ID: 25109400 [TBL] [Abstract][Full Text] [Related]
7. Submicron Matrices Embedded in a Polymeric Caplet for Extended Intravaginal Delivery of Zidovudine. Mashingaidze F; Choonara YE; Kumar P; du Toit LC; Maharaj V; Buchmann E; Pillay V AAPS J; 2017 Nov; 19(6):1745-1759. PubMed ID: 28779379 [TBL] [Abstract][Full Text] [Related]
8. Innovations in bioadhesive vaginal drug delivery system. Bassi P; Kaur G Expert Opin Ther Pat; 2012 Sep; 22(9):1019-32. PubMed ID: 22860765 [TBL] [Abstract][Full Text] [Related]
9. Studies on vaginal bioadhesive tablets of acyclovir. Genç L; Oğuzlar C; Güler E Pharmazie; 2000 Apr; 55(4):297-9. PubMed ID: 10798244 [TBL] [Abstract][Full Text] [Related]
10. Development and characterization of polymer-coated liposomes for vaginal delivery of sildenafil citrate. Refai H; Hassan D; Abdelmonem R Drug Deliv; 2017 Nov; 24(1):278-288. PubMed ID: 28165805 [TBL] [Abstract][Full Text] [Related]
11. Poly(ethylene glycol) enclatherated pectin-mucin submicron matrices for intravaginal anti-HIV-1 drug delivery. Mashingaidze F; Choonara YE; Kumar P; du Toit LC; Maharaj V; Buchmann E; Pillay V Int J Pharm; 2016 Apr; 503(1-2):16-28. PubMed ID: 26943973 [TBL] [Abstract][Full Text] [Related]
12. Assessment of diffusion coefficient from mucoadhesive barrier devices using artificial neural networks. Lee Y; Khemka A; Yoo JW; Lee CH Int J Pharm; 2008 Mar; 351(1-2):119-26. PubMed ID: 17981411 [TBL] [Abstract][Full Text] [Related]
13. Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract. Lehr CM Crit Rev Ther Drug Carrier Syst; 1994; 11(2-3):119-60. PubMed ID: 7600586 [TBL] [Abstract][Full Text] [Related]
14. Vaginal mucoadhesive drug delivery systems. de Araújo Pereira RR; Bruschi ML Drug Dev Ind Pharm; 2012 Jun; 38(6):643-52. PubMed ID: 21999572 [TBL] [Abstract][Full Text] [Related]
15. Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir. Mohideen M; Quijano E; Song E; Deng Y; Panse G; Zhang W; Clark MR; Saltzman WM Biomaterials; 2017 Nov; 144():144-154. PubMed ID: 28829952 [TBL] [Abstract][Full Text] [Related]
16. Development and in vitro evaluation of an acid buffering bioadhesive vaginal gel for mixed vaginal infections. Ahmad FJ; Alam MA; Khan ZI; Khar RK; Ali M Acta Pharm; 2008 Dec; 58(4):407-19. PubMed ID: 19103575 [TBL] [Abstract][Full Text] [Related]
17. Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery. Kieweg SL; Katz DF J Biomech Eng; 2006 Aug; 128(4):540-53. PubMed ID: 16813445 [TBL] [Abstract][Full Text] [Related]
18. Once daily bioadhesive vaginal clotrimazole tablets: design and evaluation. Sharma G; Jain S; Tiwary AK; Kaur G Acta Pharm; 2006 Sep; 56(3):337-45. PubMed ID: 19831282 [TBL] [Abstract][Full Text] [Related]
19. Polymer-lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate. Albertini B; Passerini N; Di Sabatino M; Vitali B; Brigidi P; Rodriguez L Eur J Pharm Sci; 2009 Mar; 36(4-5):591-601. PubMed ID: 19150403 [TBL] [Abstract][Full Text] [Related]
20. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study. Omar RF; Trottier S; Brousseau G; Lamarre A; Alexandre Gagnon ; Bergeron MG Contraception; 2008 Jun; 77(6):447-55. PubMed ID: 18477496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]